NDC00006-3239-66 — CHLOROTHIAZIDE ORAL SUSPENSION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00006-3239-66: CHLOROTHIAZIDE ORAL SUSPENSION.

The CHLOROTHIAZIDE ORAL SUSPENSION is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 237.000 MILLILITERS, active_medicament_medicinal_strength: 250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS, part_name_assigned_by_controlling_agency: CHLOROTHIAZIDE ORAL SUSPENSION USP 250MG/5ML 237ML BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-156-1600, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00006-3239-66

NSN: 6505-01-156-1600
FSC: 6505 — Drugs and Biologicals
CAGE: 06990 — MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH (USA)

SPECIFICATIONS

primary_container_type	BOTTLE
protective_storage_feature	SUBJECT TO DAMAGE BY FREEZING
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	237.000 MILLILITERS
active_medicament_medicinal_strength	250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS
part_name_assigned_by_controlling_agency	CHLOROTHIAZIDE ORAL SUSPENSION USP 250MG/5ML 237ML BT
NSN	6505-01-156-1600

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	237.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
PROTECTIVE STORAGE FEATURE	SUBJECT TO DAMAGE BY FREEZING
PART NAME ASSIGNED BY CONTROLLING AGENCY	CHLOROTHIAZIDE ORAL SUSPENSION USP 250MG/5ML 237ML BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	250.000 MILLIGRAMS CHLOROTHIAZIDE PER 5 MILLILITERS

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

DIURILReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00006-3239-66?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00006-3239-66?

NDC00006-3239-66 is a CHLOROTHIAZIDE ORAL SUSPENSION.

What parts can replace NDC00006-3239-66?

There is 1 known substitute for NDC00006-3239-66: DIURIL. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00006-3239-66?

NDC00006-3239-66 is cataloged in the U.S. Government catalog under NSN 6505-01-156-1600. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00006-3239-66 — CHLOROTHIAZIDE ORAL SUSPENSION

Request a Quote — NDC00006-3239-66